Skip to main content
Premium Trial:

Request an Annual Quote

Strata Biosciences Appoints Lane CEO

Premium

ALAMEDA, Calif.--Strata Bio sciences, a functional genomics company here that uses proprietary technologies combining molecular biology, high-throughput screening, and cell-based models to discover disease causing genes, has hired Douglas Lane as president and CEO. Lane was recently vice-president of genomic research at CapCURE, a foundation seeking cures for prostate cancer. Previously, he was vice-president of corporate development at Hyseq and spent seven years in the position of business development director for SmithKline Beecham where he was instrumental in managing alliances with Human Genome Sciences and the Institute for Genomic Research.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.